- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00877968
Glycemic Responses and Sensory Characteristics of Whole Yellow Pea Flour Added to Novel Functional Foods
Study Overview
Status
Conditions
Intervention / Treatment
- Dietary supplement: Whole wheat banana bread
- Dietary supplement: Whole pea flour banana bread
- Dietary supplement: Whole wheat biscotti
- Dietary supplement: Whole pea flour biscotti
- Dietary supplement: Whole wheat pasta
- Dietary supplement: Whole pea pasta
- Dietary supplement: White bread
- Dietary supplement: Boiled yellow peas
Detailed Description
Pulses, including yellow peas, are readily available and low-cost commodities that are gaining considerable momentum as functional ingredients possessing health benefits, as these food materials are high in fiber, protein, antioxidants, and low in fat. As incidence rates of type II diabetes continue to climb, new novel ingredients that produce low-glycemic food products are in demand. Consumption of whole pulses have been shown to lower post-prandial glycemic responses (Jenkins and others 1983), however, their addition to foods often produces unfavorable sensory characteristics. To date, few studies have examined the feasibility of producing food products containing pulse-derived ingredients that reduce post-prandial glycemic responses, lower glycemic indexes (GI) and at the same time possess sensory qualities that appeal to consumers. Since yellow peas are readily available and relatively inexpensive, they are a promising candidate for use as novel ingredients for the development of low-glycemic, consumer-friendly functional foods.
The objective of the present study was to first determine the post-prandial glycemic response and GI of novel foods containing whole yellow pea flour (WYPF) as a functional ingredient. The second objective was to determine the acceptability of sensory characteristics for each WYPF food product.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R3T 2N2
- Richardson Centre for Functional Foods and Nutraceuticals
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- healthy men
- non-lactating women
- BMI's between 18 and 31 kg/m2
Exclusion Criteria:
- heart disease
- diabetes
- thyroid disease
- celiac disease
- gluten intolerance
- taking corticosteroid medications
- smokers
- Chronic alcohol usage (> 2 drinks/d)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Whole wheat banana bread
Banana bread made with whole wheat flour
|
Dose was portioned so that subjects received 50 g available carbohydrate Portion: 62.8 g Available CHO: 51.7 g |
Active Comparator: Whole pea flour banana bread
Banana bread made with whole pea flour
|
Dose was portioned so that subjects received 50 g available carbohydrate Portion: 67.8 g Available CHO: 52.0 g |
Placebo Comparator: Whole wheat biscotti
Biscotti made with whole wheat flour
|
Dose was portioned so that subjects received 50 g available carbohydrate Portion: 79.8 g Available CHO: 53.1 g |
Active Comparator: Whole pea biscotti
Biscotti made with whole pea flour
|
Dose was portioned so that subjects received 50 g available carbohydrate Portion: 86 g Available CHO: 51.7 g |
Placebo Comparator: Whole wheat pasta
Pasta made with whole wheat durum
|
Dose was portioned so that subjects received 50 g available carbohydrate Portion (Dry): 70 g Available CHO: 51.1 g |
Active Comparator: Whole pea flour
Pasta made with 30% whole pea flour and 70% white wheat durum
|
Dose was portioned so that subjects received 50 g available carbohydrate Pea pasta is 30% whole pea pasta, 70 white wheat durum Portion (Dry pasta) : 90 g Available CHO: 53.1 g |
Placebo Comparator: White bread
|
Dose was portioned so that subjects received 50 g available carbohydrate Portion: 100 g Available CHO: 50 g |
Placebo Comparator: Boiled yellow peas
|
Dose was portioned so that subjects received 50 g available carbohydrate Portion: 100 g (dry) --> 250 g cooked Available CHO: 52.8 g |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Post-prandial glycemic response
|
Secondary Outcome Measures
Outcome Measure |
---|
Comparison of hedonic sensory characteristics between corresponding food products
|
Appearance, taste, texture, smell and overall acceptability
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Peter JH Jones, PhD, University of Manitoba
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- B2008:017
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
-
Garvan Institute of Medical ResearchWeizmann Institute of ScienceActive, not recruitingType 2 Diabetes Mellitus | Pre DiabetesAustralia
-
Oregon State UniversitySanofiCompletedType I or Type II Diabetes (Excludes Gestational Diabetes)
-
Taichung Veterans General HospitalNational Health Research Institutes, TaiwanRecruitingDiabetes Complications | Type 2 Diabetes | Maturity-Onset Diabetes of the Young (MODY)Taiwan
-
University of RoehamptonRecruitingType2 Diabetes Mellitus | Pre DiabetesUnited Kingdom
-
University of ReadingCompletedDiabetes, Type 2 | Diabetes Mellitus, Noninsulin-DependentUnited Kingdom, Kuwait
Clinical Trials on Whole wheat banana bread
-
Harokopio UniversityNational and Kapodistrian University of AthensCompleted
-
Ohio State UniversityUSDA Beltsville Human Nutrition Research CenterActive, not recruitingInflammation | PreDiabetes | Endotoxemia | DysbiosisUnited States
-
TNONederlands Bakkerij Centrum; PepsiCo, Inc.Completed
-
TC Erciyes UniversityCompleted
-
Universidade do PortoCenter for Health Technology and Services Research; Project VALORINTEGRADOR...CompletedHealthy VolunteersPortugal
-
Agricultural University of AthensCompletedAppetitive Behavior | Potential Abnormality of Glucose ToleranceGreece
-
University of HohenheimUniversity Hospital Schleswig-HolsteinRecruitingNon-celiac Gluten Sensitivity | Wheat HypersensitivityGermany
-
Harokopio UniversityJOTIS S.A. FOOD INDUSTRY, GREECECompleted
-
University of Eastern FinlandVTT Technical Research Centre of FinlandCompletedGlucose Metabolism Disorders | Inflammation | Intestinal Disorder
-
Swedish University of Agricultural SciencesGood Food Practice, Sweden; Lantmännen R&DCompleted